Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unintended consequences of legacy oversight in digital medicine.

Nature medicine·2026
Same author

Clinical pathology and laboratory medicine capacity across a sample of Malawian institutions: a cross-sectional survey.

American journal of clinical pathology·2026
Same author

Clinical and analytical validation of a combined RNA and DNA exome assay across a large tumor cohort.

Communications medicine·2025
Same author

Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture.

Science advances·2025
Same author

Duvelisib with Docetaxel for Patients with Anti-PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

Harmonized cross-species cell atlases of trigeminal and dorsal root ganglia.

Science advances·2024
Same journal

Correction: Yalçın et al. Impact of SGLT2 Inhibitors on Cardiovascular Risk Scores, Metabolic Parameters, and Laboratory Profiles in Type 2 Diabetes. <i>Life</i> 2025, <i>15</i>, 722.

Life (Basel, Switzerland)·2026
Same journal

Correction: Schubert et al. Minimally Invasive Ablation Strategies for Renal Cell Carcinoma Patients Ineligible for Surgery. <i>Life</i> 2026, <i>16</i>, 73.

Life (Basel, Switzerland)·2026
Same journal

Blood Group Antigen Combinations and COVID-19: Complexity, Associations and Possible Clinical Relevance.

Life (Basel, Switzerland)·2026
Same journal

Beyond HPV in Eastern Europe: Genotype Distribution, Molecular Biomarkers, Vaginal Microbiome, and Implications for Cervical Cancer Prevention.

Life (Basel, Switzerland)·2026
Same journal

Therapeutic Effects of <i>Scutellaria baicalensis</i> Georgi Extract and Baicalein on Olfactory Dysfunction and Neurobehavioral Alterations in a Methimazole-Induced Injury Model.

Life (Basel, Switzerland)·2026
Same journal

The Effects of Unstable Strength Training on Lower Limb Stability in Adolescent Volleyball Players in China.

Life (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Jun 18, 2025

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

16.8K

Technology and Future of Multi-Cancer Early Detection.

Danny A Milner1,2, Jochen K Lennerz3

  • 1Harvard T. H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.

Life (Basel, Switzerland)
|July 27, 2024
PubMed
Summary
This summary is machine-generated.

Multi-omics approaches, integrating genomic, transcriptomic, proteomic, and metabolomic data, offer enhanced sensitivity and specificity for early cancer detection. This advancement promises improved patient outcomes and personalized cancer care through advanced diagnostics.

Keywords:
biomarkerearly detectionprecision oncology

More Related Videos

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

8.6K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

1.9K

Related Experiment Videos

Last Updated: Jun 18, 2025

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

16.8K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

8.6K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

1.9K

Area of Science:

  • Oncology and Bioinformatics
  • Biomedical Diagnostics

Background:

  • Cancer poses a significant global health burden with high morbidity and mortality.
  • Current early cancer detection methods often lack sufficient sensitivity and specificity.
  • Improved diagnostic tools are crucial for better patient outcomes.

Purpose of the Study:

  • To explore the potential of multi-omics approaches for enhancing early cancer detection.
  • To address the challenges and highlight the benefits of integrating diverse omics data.
  • To demonstrate how multi-omics can revolutionize cancer diagnostics.

Main Methods:

  • Integration of multi-omics data: genomic, transcriptomic, proteomic, and metabolomic data.
  • Analysis of data integration challenges and benefits.
  • Review of successful multi-omics applications in other scientific fields.

Main Results:

  • Multi-omics integration can significantly improve diagnostic sensitivity and specificity for early-stage cancers.
  • Successful examples demonstrate the utility of multi-omics in complex biological systems.
  • The approach holds promise for more accurate and timely cancer identification.

Conclusions:

  • Multi-omics approaches represent a transformative potential for early cancer detection.
  • These integrated methods can lead to better patient outcomes and personalized cancer care.
  • Continued research and clinical integration are essential for realizing the full potential of multi-omics in oncology.